Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency

Diabetologia

Volumn 45, Issue 3, 2002, Pages 378-384

  Holzl B ^a   Iglseder, B ^b   Sandhofer, A ^c   Malaimare, L ^a   Lang, J ^a   Paulweber, B ^a   Sandhofer, F ^a  

^a St Johanns Spital   (Austria)

^b Christian Doppler Klinik   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Atherosclerotic vascular disease; Gene mutation; Insulin resistance; Intima media thickness; Lipoprotein lipase; Lipoproteins

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME DEFICIENCY; FEMALE; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; ALTERNATIVE SPLICING; AMINO ACID SUBSTITUTION; BLOOD GLUCOSE; BLOOD PRESSURE MONITORING, AMBULATORY; BODY MASS INDEX; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; INSULIN; INSULIN RESISTANCE; INTRONS; LIPOPROTEIN LIPASE; MUTATION, MISSENSE; TRIGLYCERIDES;

EID: 0036210617     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0771-8     Document Type: Article

References (27)

1. Lipolytic enzymes and plasma lipoprotein metabolism
2. Common variation in the lipoprotein lipase gene: Effects on plasma lipids and risk of atherosclerosis
3. Mutations affecting human lipoprotein lipase gene
4. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome
5. Molecular basis of lipoprotein lipase deficiency in two Austrian families with type I hyperlipoproteinemia
6. Common mutations of the lipoprotein lipase gene and their clinical significance
7. Functional variants in the lipoprotein lipase gene and risk cardiovascular disease
8. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation
9. Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French-Canadian population
10. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities
11. Lipoprotein lipase deficiency due to a 3′ splice site mutation in intron 6 of the lipoprotein lipase gene
12. Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23
13. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
14. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III
15. Rationale and design for the Asymptomatic Carotid Artery Plaque Study (ACAPS)
16. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipoprotein lipase deficiency
17. Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency
18. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency
19. Missense mutation (Gly - Glu188) of human lipoprotein lipase imparting functional deficiency
20. A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals
21. Deoxyribonucleic acid polymorphism in the apolipoprotein A-1-C-III gene cluster. Association with hypertriglyceridemia
22. Genetic variation in the apolipoprotein AI-CIII-AIV gene cluster and coronary heart disease
23. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
24. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
25. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III
26. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E
27. Heterozygous lipoprotein lipase deficiency: Frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease